This development represents a setback for Walgreens, which has made previous attempts to go private. In 2019, the pharmacy chain was valued at over $55 billion but failed to secure a deal.

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York private-equity firm Sycamore Partners is “mostly dead.” Walgreen’s ...

Walgreens Boots Alliance (WBA) stock is falling in Monday's afternoon trading following reports that its potential privatization deal with Sycamore Partners has collapsed. According to CNBC ...

CNBC’s David Faber reported on air this morning that sources say the possible deal in which Walgreens would sell itself to New York-based Sycamore Partners is “mostly dead.” One count ...

Investing.com -- Shares of Walgreens (NASDAQ: WBA) fell sharply by 9% following reports that a potential acquisition by private equity firm Sycamore Partners may not materialize. CNBC's David Faber ...

The first full trading week of the year is ... Other reports said that such a deal could trigger a fresh auction of UK chain Boots, which is part of the larger Walgreens Boots Alliance business.